Exondys 51

Eteplirsen

Eteplirsen (brand name Exondys 51) is a medication to treat, but not cure, some types of Duchenne muscular dystrophy (DMD), caused by a specific mutation. Eteplirsen only targets specific mutations and can be used to treat about 14% of DMD cases.[1][2] Eteplirsen is a form of antisense therapy. Eteplirsen was developed by Steve Wilton, Sue Fletcher and colleagues at the University of Western Australia and commercialized by Sarepta Therapeutics.[3&#9...

Drug Index

Eteplirsen (brand name Exondys 51) is a medication to treat, but not cure, some types of Duchenne muscular dystrophy (DMD), caused by a specific mutation. Eteplirsen only targets specific mutations and can be used to treat about 14% of DMD cases.[1][2] Eteplirsen is a form of antisense therapy. Eteplirsen was developed by Steve Wilton, Sue Fletcher and colleagues at the University of Western Australia and commercialized by Sarepta Therapeutics.[3&#9...

Please provide me with more details about the use of "Exondys 51" injections for muscular dystrophy problems.

NDC Database

Exondys 51 50 mg/ml Intravenous Injection by Sarepta Therapeutics, Inc. ## Package Codes: 60923-284-10 ## Active Ingredients: Eteplirsen

NDC Database

Exondys 51 50 mg/ml Intravenous Injection by Sarepta Therapeutics, Inc. ## Package Codes: 60923-363-02 ## Active Ingredients: Eteplirsen